VOYA Investment Management’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.3M | Sell |
29,786
-8,838
| -23% | -$386K | ﹤0.01% | 1457 |
|
|
2025
Q1 | $1.06M | Sell |
38,624
-22,519
| -37% | -$616K | ﹤0.01% | 1539 |
|
|
2024
Q4 | $2.46M | Sell |
61,143
-1,034
| -2% | -$41.6K | ﹤0.01% | 1227 |
|
|
2024
Q3 | $2.94M | Sell |
62,177
-4,529
| -7% | -$214K | ﹤0.01% | 1209 |
|
|
2024
Q2 | $1.99M | Sell |
66,706
-3,734
| -5% | -$111K | ﹤0.01% | 1319 |
|
|
2024
Q1 | $2.83M | Sell |
70,440
-2,534
| -3% | -$102K | ﹤0.01% | 1209 |
|
|
2023
Q4 | $1.86M | Sell |
72,974
-21
| -0% | -$535 | ﹤0.01% | 1397 |
|
|
2023
Q3 | $1.01M | Buy |
72,995
+316
| +0.4% | +$4.39K | ﹤0.01% | 1624 |
|
|
2023
Q2 | $1.67M | Buy |
72,679
+583
| +0.8% | +$13.4K | ﹤0.01% | 1423 |
|
|
2023
Q1 | $2.14M | Sell |
72,096
-183
| -0.3% | -$5.42K | ﹤0.01% | 1334 |
|
|
2022
Q4 | $1.8M | Buy |
72,279
+20,435
| +39% | +$510K | ﹤0.01% | 1377 |
|
|
2022
Q3 | $1.13M | Buy |
51,844
+37,609
| +264% | +$819K | ﹤0.01% | 1569 |
|
|
2022
Q2 | $280K | Buy |
14,235
+247
| +2% | +$4.86K | ﹤0.01% | 2215 |
|
|
2022
Q1 | $592K | Buy |
13,988
+414
| +3% | +$17.5K | ﹤0.01% | 1808 |
|
|
2021
Q4 | $861K | Buy |
13,574
+273
| +2% | +$17.3K | ﹤0.01% | 1647 |
|
|
2021
Q3 | $781K | Buy |
13,301
+1,906
| +17% | +$112K | ﹤0.01% | 1761 |
|
|
2021
Q2 | $553K | Buy |
+11,395
| New | +$553K | ﹤0.01% | 2025 |
|
|
2021
Q1 | – | Sell |
-3,881
| Closed | -$241K | – | 2764 |
|
|
2020
Q4 | $241K | Buy |
+3,881
| New | +$241K | ﹤0.01% | 2325 |
|